ENFA

890 5th Avenue Partners, Inc.

9.62
USD
-2.93%
9.62
USD
-2.93%
8.50 11.23
52 weeks
52 weeks

Mkt Cap 284.06M

Shares Out 29.53M

Send me real-time posts from this site at my email

CSL annual profit drops 6% as weak plasma collections bite

Aug 17 (Reuters) - Australian biomedical giant CSL Ltd CSL.AX on Wednesday reported a 6% drop in annual profit as collections of plasma, the key ingredient of its treatments, were subdued in the first half and hit sales of core plasma therapies. CSL posted an underlying net profit after tax of $2.24 billion on a constant currency basis for the year ended June 30. (Reporting by Roushni Nair in Bengluru; Editing by Shailesh Kuber) ((Roushni.Nair@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue